FDA Approves INTERCEPT Blood System for Plasma

December 16, 2014 10:33 PM

16 0

Cerus’ Blood Safety Technology is Indicated to Reduce the Risk of Transfusion-Transmitted Infections from Plasma Components

CONCORD, Calif., Dec 16, 2014 (BUSINESS WIRE) -- Cerus Corporation CERS, +3.02% today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk o...

Read more

To category page